What is the WHO essential medicines list?

被引：16

作者：

Purgato, M. ^{[1
]}

Barbui, C. ^{[1
]}

机构：

[1] Univ Verona, Sect Psychiat, Dept Publ Hlth & Community Med, Verona, Italy

来源：

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES | 2012年 / 21卷 / 04期

关键词：

Essential list of medicines; mental health; psychotropic drugs; World Health Organization; NEEDS;

D O I：

10.1017/S204579601200039X

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article briefly presents the main characteristics of the World Health Organization (WHO) essential medicines list (EML), a register of minimum medicine needs for every health-care system. The idea behind the list is that the use of a limited number of well-known and cost-effective medicines may lead to improved long-term medicine supply, lower costs and better health care provision. Received 6 June 2012; Revised 7 June 2012; Accepted 12 June 2012; First published online 30 July 2012

引用

页码：343 / 345

页数：3

共 10 条

[1] WHO needs change [J].

Bloom, Barry R. .

NATURE, 2011, 473 (7346) :143-145

[2] Making the List: The Role of Essential Medicines Lists In Reproductive Health [J].

Hutchings, Jane ;

Neroutsos, Keith ;

Donnelly, Kathleen .

INTERNATIONAL PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2010, 36 (04) :205-208

[3] Adding a Medicine to the WHO Model List of Essential Medicines [J].

Kishore, S. P. ;

Herbstman, B. J. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) :237-239

[4] 25 years of the WHO essential medicines lists: progress and challenges [J].

Laing, R ;

Waning, B ;

Gray, A ;

Ford, N ;

't Hoen, E .

LANCET, 2003, 361 (9370) :1723-1729

[5] The Cochrane Collaboration as key player in the struggle for better and more relevant patients- and system-oriented research [J].

Liberati, A. .

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2011, 20 (03) :225-230

[6] Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs [J].

Purgato, Marianna ;

Barbui, Corrado ;

Adams, Clive E. .

INTERNATIONAL JOURNAL OF MENTAL HEALTH SYSTEMS, 2011, 5

[7]

WHO, 2009, WHO TECH REP SER, V958, P1

[8]

World Health Organization, 2011, Model List of Essential Medicines

[9]

World Health Organization, 2011, mhGAP intervention guide for mental, neurological and substance use disorders in nonspecialized health settings

[10]

World Health Organization, 2011, WHO LIST REJ DRUGS L

← 1 →